Stereotaxis, Inc. Appoints Kevin M. Barry as New Chief Legal Officer, Corporate Secretary and Chief Compliance Officer, Effective November 5, 2018
October 30, 2018 at 09:00 am EDT
Share
On October 30, 2018, Stereotaxis, Inc. announced that it had appointed Kevin M. Barry as its new Chief Legal Officer, Corporate Secretary and Chief Compliance Officer, effective November 5, 2018. Mr. Barry will join the Company from BioFire Diagnostics, where he served as the Vice President of Legal Affairs and Chief Compliance Officer. Prior to that, Mr. Barry served in senior legal roles for Sonova Group, CareFusion, and Cardinal Health.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Companyâs primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
STEREOTAXIS, INC. 
